Nottingham BRC Signs for Open Innovation Platform

The Labmate website reported that leading research teams at the NIHR Nottingham Biomedical Research Centre are to collaborate over the next two years with their counterparts in the IMED Biotech Unit at global biopharmaceutical company, Astra Zeneca. Nottingham is the first NIHR Biomedical Research Centre in the UK to formally establish a collaboration with AstraZeneca’s Open Innovation platform, which provides the opportunity for teams working in six areas of clinical research. Professor Ian Hall, Director of the NIHR Nottingham BRC  said “One of the fundamental differences that biomedical research centres such as the one in Nottingham can make is in building partnerships across health, research and industry to translate innovation into new treatments for patients.”

Click here to read the full article.
.
Image via Flickr.